Hess Downgraded to Mkt Perform and 3 Stock Downgraded Shares to Eye

November 12, 2012

Wall St. Watchdog reveals information about companies for which stock analysts downgraded the shares on November 12th.

CreXus Investment (NYSE:CXS): Ladenburg Thalmann downgraded its rating on this company from Buy to Neutral.

Idenix Pharma (NASDAQ:IDIX): Maxim Group downgraded its rating on this company from Buy to Hold and changed its price target from $11 to $5.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

SandRidge Energy (NYSE:SD): Global Hunter Securities downgraded its rating on this company from Buy to Neutral and changed its price target from $9 to $5.

Hess (NYSE:HES): Howard Weil downgraded its rating on this company from Market Outperform to Market Perform and changed its price target from $57 to $55.

Don’t Miss: This Country Will Lead Oil Output by 2020.

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com